Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
Spero Therapeutics, a clinical-stage biopharmaceutical company focused on rare diseases and high unmet needs, plans to release its Q1 2026 financial results and provide a business update on May 13, 2026, after market close. No conference call is scheduled.